Innoviva (INVA) Cash from Investing Activities (2010 - 2026)

Innoviva (INVA) posted Cash from Investing Activities of $37.0 million for Q1 2026, up 119.5% on a QoQ basis from $16.9 million in Q3 2025, and up 206.73% year-over-year from $12.1 million in Q1 2025.

Innoviva (INVA) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Innoviva's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at $37.0 million for Q1 2026.

  • Quarterly Cash from Investing Activities rose 206.73% year-over-year to $37.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $52.3 million (up 141.51% YoY) and the FY2025 annual result came in at $40.5 million, up 163.49% from the prior year.
  • Cash from Investing Activities was $37.0 million for Q1 2026 at Innoviva, up from $16.9 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $37.0 million in Q1 2026 and bottomed at -$143.2 million in Q1 2022.
  • A 5-year average of -$30.0 million and a median of -$35.7 million in 2023 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 442.38% — and 2026, when it soared 206.73%.
  • Innoviva's Cash from Investing Activities stood at -$48.0 million in 2022, then decreased by 28.47% to -$61.6 million in 2023, then advanced by 21.59% to -$48.3 million in 2024, then soared by 134.9% to $16.9 million in 2025, then soared by 119.5% to $37.0 million in 2026.
  • Business Quant data shows INVA's Cash from Investing Activities at $37.0 million in Q1 2026, $16.9 million in Q3 2025, and $33.1 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 172.62 Mn
10 Innoviva 1.58 Bn 979.49 Mn 75.83 Mn 37.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 37.01 Mn
Mar 31, 2026 37.01 Mn
Sep 30, 2025 16.86 Mn
Sep 30, 2025 16.86 Mn
Jun 30, 2025 33.12 Mn
Jun 30, 2025 33.12 Mn
Mar 31, 2025 -34.67 Mn
Mar 31, 2025 -34.67 Mn
Sep 30, 2024 -48.31 Mn
Sep 30, 2024 -48.31 Mn
Mar 31, 2024 -43.04 Mn
Mar 31, 2024 -43.04 Mn
Sep 30, 2023 -61.61 Mn
Sep 30, 2023 -61.61 Mn
Mar 31, 2023 -35.72 Mn
Mar 31, 2023 -35.72 Mn
Sep 30, 2022 -47.96 Mn
Sep 30, 2022 -47.96 Mn
Jun 30, 2022 -2.52 Mn
Jun 30, 2022 -2.52 Mn